금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
Nasdaq raises red flag on 3 overnight risks ahead of Dec. 6 — and they pose an extra-big threat to retirement nest eggs
Extended 23-hour trading starts Dec. 6 — and thin overnight liquidity can devastate retirees' nest e...
‘Non-answers’ aren’t working. This is what investors really need from the Fed.
What really matters to investors, economists say, is for Fed Chairman Kevin Warsh to prove he can su...
With the S&P 500 Setting Record Highs, History Points to 1 Clear Move
Investors holding the Vanguard S&P 500 ETF and related funds very much want history to repeat.
Investors Heavily Search Super Micro Computer, Inc. (SMCI): Here is What You Need to Know
Super Micro (SMCI) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Intellia rises on FDA priority review for one-time hereditary angioedema therapy
Why Micron Technology Stock Surged 16.5% Last Month
Micron is up more than 250% year to date, and it's set to release a crucial quarterly report at the end of September.
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
Kinross Gold Stock Up 13% in a Month: What Should Investors Do Now?
KGC's 13% gain reflects stronger gold prices and earnings, but rising costs and falling estimates cloud its outlook.
IonQ rises as it boosts guidance after SkyWater deal, launches Superion products, more
These ten materials stocks pair strong revenue growth with A-rated valuations
Longevity Health enters into securities purchase agreement for up to $625,000 in gross proceeds
Eupraxia Pharmaceuticals Completes Transfer to the Nasdaq Global Select Market and Announces Participation in Upcoming Investor Conferences
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (Nasdaq: EPRX) (TSX: EPRX), a clinical-stage biotechnology company leveragin ...
Intel rises amid Northland Securities upgrade, price hike report
CME Group to enter European dairy market through EEX deal